Trends and projected burden of early-onset gastrointestinal malignancies in the United States: a population-based analysis (2001-2021)
JNCI: Journal of the National Cancer Institute · 2026
DOI: 10.1093/jnci/djaf304 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2026. Verfasst von Abdul Qahar K Yasinzai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal Oncology, University of Florida Health Cancer Institute, Gainesville, FL, United States. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: AstraZeneca, Bristol Myers Squibb.
Abstract (Originalsprache)
Background
Early-onset colorectal cancer (CRC) has become a serious public health concern in recent years. This study aimed to contribute to the growing body of evidence on the rise in early-onset gastrointestinal (GI) cancers and anatomical subsites of early-onset CRC, and to explore racial and sex disparities in these trends.
Methods
We analyzed data from the National Program of Cancer Registries–Surveillance, Epidemiology, and End Results database (2001-2021) for people aged 20 to 49 years with GI cancers. The dataset covers cancer incidence rates for approximately 98% of the US population. Joinpoint regression was used to calculate average annual percent change, and polynomial regression was applied to forecast rates from 2021 to 2031.
Results
A total of 527 411 cases were analyzed. Colorectal cancer made up the highest number of cases (n = 313 513), followed by pancreatic cancer (n = 50 448). Intrahepatic bile duct cancer saw the highest average annual percent change (+6.24%, 95% CI = 5.20 to 7.45), followed by small intestine cancer (+3.19%, 95% CI = 2.69 to 3.72), early-onset CRC (+1.65%, 95% CI = 1.45 to 1.92), pancreatic cancer (+1.52, 95% CI = 1.37 to 1.66), and stomach cancer (+1.20, 95% CI = 0.89 to 1.53). Among CRC cases, rectal cancer had the highest average annual percent change (+2.09%). Women (+1.81%) experienced a disproportionate rise to men (+0.83%). Our projection suggests a demographic shift, with women surpassing men in the overall age-adjusted rate of early-onset GI cancers.
Conclusion
The study highlights that early-onset CRC is not an isolated phenomenon but part of a broader epidemiologic shift across GI malignancies. The parallel rise in cancers of other sites suggests shared upstream risk factors or exposures and supports investigations into potential environmental, dietary, microbiome, and hormone risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastrointestinal Oncology, University of Florida Health Cancer Institute, Gainesville, FL, United States.
- Division of Gastrointestinal Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
- Division of Gastrointestinal Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, United States.
ORCID-Profile: Abdul Qahar K Yasinzai, Pooya Jalali, Sebawe Syaj, Ibrahim Halil Sahin, Ibrahim Nassour, Thomas J George, Anwaar Saeed
Förderung
- AstraZeneca
- Bristol Myers Squibb
Zitieren
APA
Yasinzai, A. Q. K., Jalali, P., Syaj, S., Sahin, I. H., Nassour, I., George, T. J., & Saeed, A. (2026). Trends and projected burden of early-onset gastrointestinal malignancies in the United States: a population-based analysis (2001-2021). JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf304
Vancouver
Yasinzai AQK, Jalali P, Syaj S, Sahin IH, Nassour I, George TJ, et al. Trends and projected burden of early-onset gastrointestinal malignancies in the United States: a population-based analysis (2001-2021). JNCI: Journal of the National Cancer Institute. 2026. doi:10.1093/jnci/djaf304
BibTeX
@article{Yasinzai2026,
author = {Yasinzai, Abdul Qahar K and Jalali, Pooya and Syaj, Sebawe and Sahin, Ibrahim Halil and Nassour, Ibrahim and George, Thomas J and Saeed, Anwaar},
title = {Trends and projected burden of early-onset gastrointestinal malignancies in the United States: a population-based analysis (2001-2021)},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2026},
doi = {10.1093/jnci/djaf304}
}
EUVIMED